UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of cardiovascular magnetic resonance, ISSN 1097-6647, 2015, Volume 17, Issue 1, pp. 58 - 58
Gadolinium | "Off-label use" | Safety | Cardiovascular magnetic resonance | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Severity of Illness Index | Acute Disease | Risk Assessment | Adverse Drug Reaction Reporting Systems | Humans | Magnetic Resonance Imaging - adverse effects | Risk Factors | Drug-Related Side Effects and Adverse Reactions - ethnology | Europe - epidemiology | Gadolinium - adverse effects | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Patient Safety | Registries | Drug-Related Side Effects and Adverse Reactions - diagnosis | Cardiovascular Diseases - diagnosis | Complications and side effects | Surface active agents | Contrast media | Index Medicus
Journal Article
Investigative radiology, ISSN 0020-9996, 03/2017, Volume 52, Issue 6, pp. 324 - 333
Gadodiamide | Gadobutrol | Gadolinium retention | MRI | Contrast agent | Gadoteridol | Globus pallidus | Histology | Dentate nucleus | Gadopentetate dimeglumine | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Gadolinium - administration & dosage | Injections, Intravenous | Rats, Wistar | Gadolinium - pharmacokinetics | Contrast Media - pharmacokinetics | Male | Muscle, Skeletal - metabolism | Bone and Bones - drug effects | Brain - metabolism | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Bone and Bones - metabolism | Contrast Media - administration & dosage | Mass Spectrometry | Muscle, Skeletal - drug effects | Brain - ultrastructure | Gadolinium DTPA - pharmacokinetics | Models, Animal | Gadolinium DTPA - administration & dosage | Retrospective Studies | Gadolinium DTPA - adverse effects | Heterocyclic Compounds - administration & dosage | Organometallic Compounds - adverse effects | Rodentia | Organometallic Compounds - pharmacokinetics | Rats | Gadolinium - adverse effects | Brain - drug effects | Animals | Heterocyclic Compounds - adverse effects | Skin - ultrastructure | Heterocyclic Compounds - pharmacokinetics | Skin - drug effects | Organometallic Compounds - administration & dosage | Index Medicus | gadolinium retention | histology | gadopentetate dimeglumine | gadobutrol | Original | globus pallidus | gadoteridol | contrast agent | dentate nucleus | gadodiamide
Journal Article
Investigative radiology, ISSN 0020-9996, 04/2019, Volume 54, Issue 4, pp. 191 - 197
magnetic resonance imaging | adverse events | adverse drug reaction | contrast media | gadolinium | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Gadolinium DTPA - adverse effects | Prospective Studies | Organometallic Compounds - adverse effects | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Surveys and Questionnaires - statistics & numerical data | Incidence | Young Adult | Administration, Intravenous | Contrast Media - adverse effects | Contrast Media - administration & dosage | Meglumine - administration & dosage | Adolescent | Aged, 80 and over | Adult | Female | Aged | Gadolinium DTPA - administration & dosage | Image Enhancement - methods | Meglumine - adverse effects | Cohort Studies | Organometallic Compounds - administration & dosage | Drugs | Adverse and side effects | Diagnosis | Index Medicus
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2015, Volume 66, Issue 1, pp. 159 - 169
Nephrology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Humans | Pain Management | Diabetic Nephropathies - drug therapy | Metabolic Clearance Rate | Analgesics - pharmacokinetics | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - metabolism | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Renal Insufficiency, Chronic - therapy | Anemia - drug therapy | Contrast Media - adverse effects | Drug Interactions | Patient Safety | Acute Kidney Injury - chemically induced | Anti-Bacterial Agents - adverse effects | Platelet Aggregation Inhibitors - pharmacokinetics | Platelet Aggregation Inhibitors - therapeutic use | Anemia - etiology | Kidney - physiopathology | Analgesics - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Medication Errors | Analgesics - therapeutic use | Arrhythmias, Cardiac - prevention & control | Hyperkalemia - complications | Hypoglycemic Agents - pharmacokinetics | Glomerular Filtration Rate | Hematinics - therapeutic use | Bacterial Infections - drug therapy | Hyperkalemia - physiopathology | Anticoagulants - therapeutic use | Hematinics - adverse effects | Renin-Angiotensin System - physiology | Arrhythmias, Cardiac - etiology | Gadolinium - adverse effects | Anticoagulants - adverse effects | Hyperkalemia - chemically induced | Renin-Angiotensin System - drug effects | Aged | Anticoagulants - pharmacokinetics | Iodine Compounds - adverse effects | Pharmacokinetics | Insulin - adverse effects | Insulin - therapeutic use | Index Medicus
Journal Article
Magnetic resonance imaging, ISSN 0730-725X, 2016, Volume 34, Issue 10, pp. 1383 - 1390
Radiology | Gadolinium deposition disease | NSF | Survey | Gadolinium toxicity | Gadolinium based contrast agents | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Gadolinium DTPA - adverse effects | Prospective Studies | Organometallic Compounds - adverse effects | Humans | Meglumine - urine | Middle Aged | Male | Gadolinium - adverse effects | Pain - chemically induced | Meglumine - analogs & derivatives | Gadolinium - urine | Magnetic Resonance Imaging | Contrast Media - adverse effects | Heterocyclic Compounds - adverse effects | Adult | Female | Aged | Gadolinium DTPA - urine | Heterocyclic Compounds - urine | Organometallic Compounds - urine | Meglumine - adverse effects | Gadolinium | Index Medicus
Journal Article
Investigative radiology, ISSN 0020-9996, 2017, Volume 52, Issue 6, pp. 317 - 323
Gadodiamide | Gadobenate dimeglumine | Gadoversetamide | Magnetic resonance | Gadolinium | Gadolinium-based contrast agents | Safety | Dentate nucleus | Gadopentetate dimeglumine | Contrast media | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Injections, Intravenous | Gadolinium - pharmacokinetics | Humans | Contrast Media - pharmacokinetics | Muscle, Skeletal - metabolism | Bone and Bones - drug effects | Brain - metabolism | Contrast Media - adverse effects | Bone and Bones - metabolism | Muscle, Skeletal - drug effects | Gadolinium DTPA - pharmacokinetics | Marketing - legislation & jurisprudence | Meglumine - adverse effects | Gadolinium DTPA - adverse effects | Risk Assessment | Organometallic Compounds - adverse effects | Europe | Organometallic Compounds - pharmacokinetics | Gadolinium - adverse effects | Pharmacovigilance | Meglumine - analogs & derivatives | Brain - drug effects | Magnetic Resonance Imaging | Animals | Meglumine - pharmacokinetics | Practice Guidelines as Topic | Index Medicus
Journal Article
Pediatric radiology, ISSN 0301-0449, 2/2013, Volume 43, Issue 2, pp. 202 - 211
Pediatrics | Medicine & Public Health | Magnetic resonance imaging | MRI | Gadobenate dimeglumine | Oncology | Nuclear Medicine | Safety | Imaging / Radiology | Ultrasound | Neuroradiology | Contrast media | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Prevalence | Humans | Risk Factors | Child, Preschool | Infant | Male | Drug-Related Side Effects and Adverse Reactions - epidemiology | Germany - epidemiology | Meglumine - analogs & derivatives | Organometallic Compounds | Contrast Media | Magnetic Resonance Imaging - statistics & numerical data | Adolescent | Female | Child | Infant, Newborn | Complications and side effects | Usage | Dosage and administration | Methods | Safety and security measures | Fibrosis | Gadolinium | Diagnosis | Index Medicus
Journal Article
Radiology, ISSN 0033-8419, 2002, Volume 223, Issue 2, pp. 311 - 318
Contrast media, toxicity | Iodine and iodine compounds | Angiography, contrast media | Contrast media, effects | Gadolinium | Contrast media, complications | Uremia | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Gadolinium DTPA - adverse effects | Humans | Chelating Agents - chemistry | Uremia - complications | Angiography, Digital Subtraction | Radiology, Interventional | Contrast Media - adverse effects | Kidney Diseases - chemically induced | Contrast Media - chemistry | Triiodobenzoic Acids - adverse effects | Triiodobenzoic Acids - chemistry | Gadolinium DTPA - chemistry | Chelating Agents - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
9.
Full Text
Zero-inflated Poisson model based likelihood ratio test for drug safety signal detection
Statistical methods in medical research, ISSN 0962-2802, 2/2017, Volume 26, Issue 1, pp. 471 - 488
adverse event reporting system database | likelihood ratio test | expectation and maximization algorithm | false discovery rate | type I error | Statistics & Probability | Physical Sciences | Life Sciences & Biomedicine | Medical Informatics | Health Care Sciences & Services | Mathematics | Science & Technology | Mathematical & Computational Biology | Gadolinium DTPA - adverse effects | Prednisone - adverse effects | Adverse Drug Reaction Reporting Systems | Organometallic Compounds - adverse effects | United States | Humans | Data Mining | Male | Heparin - adverse effects | Fatty Alcohols - adverse effects | United States Food and Drug Administration - legislation & jurisprudence | Meglumine - analogs & derivatives | Likelihood Functions | Algorithms | Aspirin - adverse effects | Female | Poisson Distribution | Research Design | Meglumine - adverse effects | Databases, Factual | Regulatory agencies | Parameter estimation | Transportation safety | Statistical methods | Data mining | Mining | Databases | Data base management systems | Matrices | Adverse | Safety | Signals | Maximum likelihood estimates | Product safety | Signal detection | Parameters | Computer simulation | Test procedures | Critical incidents | Discovery | Likelihood ratio | Reporting | Simulation | Normal distribution | Detection | Bayesian analysis | Pharmaceuticals | Index Medicus | Drugs | Counting
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, pp. 221 - 234
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Recurrence | Brain - diagnostic imaging | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, CD20 | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Disease Progression | Interferon-beta - therapeutic use | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Interferon-beta - adverse effects | Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging | Infusions, Intravenous - adverse effects | Adult | Female | Immunologic Factors - adverse effects | Immunologic Factors - therapeutic use | Multiple sclerosis | Intravenous administration | Lymphocytes B | Lymphocytes | β-Interferon | Immunotherapy | Clinical trials | Monoclonal antibodies | CD20 antigen | Gadolinium | Cognition | Interferon | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article